Skip to content
★ Sign in to follow
DD

Daniel D. Long

Executive
Insider activity · 24 months0 buys4 salesCumulative net flow
Total declarations
7
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (4 ops.)
€263k

Latest filing published 03 Sept 2026 for Septerna, Inc., €7,920.

Filing timeline

BuySale
Daniel D. Long

Insider track record

Disclosed buys
0
Disclosed sells
4
Signal history

Daniel D. Long: trading record in brief

This profile gathers the share dealings of Daniel D. Long in Septerna, Inc. We count 7 filings; the first trade dates from 10 November 2025 and the latest from 1 September 2026.

The open-market record consists of 4 sales worth €263k, with no purchase. Besides market trades, the filings include 3 option exercises. 2026 to date brings no purchases and 3 sales.

Most recently, on 3 September 2026, the filings show an option exercise worth €7,920 in Septerna, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Daniel D. Long

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations7 total
  • ◇
    SVP, Drug DiscoveryExecutivesSepterna, Inc.
    9,199 USD18SEC
    3,333 shares@ US$2.760.0005% mcap2.8% of flowCommon StockSEC:0001193125-26-382267:0
  • ▼
    SVP, Drug DiscoveryExecutivesSepterna, Inc.
    126,078 USD40SEC
    3,333 shares@ US$37.82710.0069% mcap38.9% of flowCommon StockSEC:0001193125-26-382267:1
  • ◇
    SVP, Drug DiscoveryExecutivesSepterna, Inc.
    5,012 USD18SEC
    1,816 shares@ US$2.760.0003% mcap1.6% of flowCommon StockSEC:0001193125-26-335820:0
  • ◇
    SVP, Drug DiscoveryExecutivesSepterna, Inc.
    4,190 USD18SEC
    1,518 shares@ US$2.760.0002% mcap1.3% of flowCommon StockSEC:0001193125-26-335820:1
  • ▼
    SVP, Drug DiscoveryExecutivesSepterna, Inc.
    33,976 USD31SEC
    1,000 shares@ US$33.97560.0019% mcap10.6% of flowCommon StockSEC:0001193125-26-335820:2
  • ▼
    SVP, Drug DiscoveryExecutivesSepterna, Inc.
    80,944 USD33SEC
    2,334 shares@ US$34.68050.0045% mcap25.2% of flowCommon StockSEC:0001193125-26-335820:3
  • ▼
    SVP, Drug DiscoveryExecutivesSepterna, Inc.
    63,223 USD13SEC
    3,501 shares@ US$18.058619.6% of flowCommon StockSEC:0001193125-25-280756:0

7 of 7 declarations